Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Eric Nuttall: Oil/Gas in 2026 — Where I’m Investing, Plus Prices, Supply, Demand January 21, 2026 5 Biggest Pharmaceutical ETFs for Investors in 2026 January 21, 2026 EUR sells a further 5m CRML Shares for approximately $A124m January 21, 2026